In Vitro Activity of Cefotetan Compared with That of Other Antimicrobial Agents Against Anaerobic Bacteria

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1988 Apr 1

PMID 3163908

Citations 7

Authors

H M Wexler

S M Finegold

Affiliations

Soon will be listed here.

Abstract

The activity of cefotetan against 430 strains of anaerobic bacteria was compared with that of cefoxitin, ceftizoxime, clindamycin, metronidazole, and chloramphenicol. Percent susceptible values for the Bacteroides fragilis group were 60, 80, 29, 86, 100, and 100%, respectively. Percent susceptible values for the B. fragilis species were 91, 92, 46, 98, 100, and 100%, respectively. Non-B. fragilis-group Bacteroides species were inhibited very well (90 to 100%) by all drugs except ceftizoxime (80%). Cefotetan and metronidazole were the most active agents against Clostridium difficile. Percent susceptible values for all strains were 72, 79, 44, 82, 93, and 98%, respectively.

Citing Articles

New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Younes Z, Johnson D Curr Gastroenterol Rep. 2000; 2(4):277-82.

PMID: 10981024 DOI: 10.1007/s11894-000-0019-7.

Metronidazole. A therapeutic review and update.

Freeman C, Klutman N, Lamp K Drugs. 1997; 54(5):679-708.

PMID: 9360057 DOI: 10.2165/00003495-199754050-00003.

In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.

Kato N, Kato H, Tanaka Y, Bando K, Watanabe K, Ueno K Antimicrob Agents Chemother. 1993; 37(5):957-61.

PMID: 8517721 PMC: 187861. DOI: 10.1128/AAC.37.5.957.

Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Gribble M CMAJ. 1994; 151(5):537-42.

PMID: 8069799 PMC: 1337188.

Susceptibility testing of anaerobic bacteria: myth, magic, or method?.

Wexler H Clin Microbiol Rev. 1991; 4(4):470-84.

PMID: 1747863 PMC: 358213. DOI: 10.1128/CMR.4.4.470.

References

Cutler R, Blair A, Burgess E, Parks D . Pharmacokinetics of ceftizoxime. J Antimicrob Chemother. 1982; 10 Suppl C:91-7. DOI: 10.1093/jac/10.suppl_c.91. View

Phillips I, King A, Shannon K, Warren C . Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother. 1983; 11 Suppl:1-9. DOI: 10.1093/jac/11.suppl_a.1. View

Werner H . Inhibitory activity of cefotetan and other beta-lactams against anaerobes. J Antimicrob Chemother. 1983; 11 Suppl:107-15. DOI: 10.1093/jac/11.suppl_a.107. View

Ruckdeschel G . Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study. J Antimicrob Chemother. 1983; 11 Suppl:117-24. DOI: 10.1093/jac/11.suppl_a.117. View

Guibert J, Kitzis M, Yvelin C, Acar J . Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers. J Antimicrob Chemother. 1983; 11 Suppl:201-6. DOI: 10.1093/jac/11.suppl_a.201. View

Wexler H, Finegold S . Antimicrobial resistance in Bacteroides. J Antimicrob Chemother. 1987; 19(2):143-6. DOI: 10.1093/jac/19.2.143. View

Cuchural Jr G, Tally F, Jacobus N, Gorbach S, Aldridge K, Cleary T . Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother. 1984; 26(2):145-8. PMC: 284108. DOI: 10.1128/AAC.26.2.145. View

Aldridge K, Sanders C, JANNEY A, Faro S, Marier R . Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother. 1984; 26(3):410-3. PMC: 176181. DOI: 10.1128/AAC.26.3.410. View

Wexler H, Carter W, Harris B, Finegold S . In vitro activity of cefbuperazone against anaerobic bacteria. Antimicrob Agents Chemother. 1985; 27(4):674-6. PMC: 180124. DOI: 10.1128/AAC.27.4.674. View

10.

Wexler H, Harris B, Carter W, Finegold S . In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother. 1985; 27(5):876-8. PMC: 180171. DOI: 10.1128/AAC.27.5.876. View

11.

Watt B, Brown F . The comparative in-vitro activity of cefotetan against anaerobic bacteria. J Antimicrob Chemother. 1985; 15(6):671-7. DOI: 10.1093/jac/15.6.671. View

12.

Moosdeen F, Maskell J, Philpott-Howard J, Williams J . Cefotetan activity against Gram-negative aerobes and anaerobes. J Antimicrob Chemother. 1983; 11 Suppl:59-65. DOI: 10.1093/jac/11.suppl_a.59. View